Patients that have consented to participate in the study will be randomly assigned to one of
two groups: control group or nasal steroid group. Patients in the control group will receive
normal saline inhaler. Patients in the study group will receive steroid inhaler Follow-up
visits are: baseline and weeks 2, 4, 6 after starting the spray. Intraocular pressure will be
recorded on all visits.